Intralesional ALA-PDT for residual extramammary Paget's disease: a case report - Summary - MDSpire

Intralesional ALA-PDT for residual extramammary Paget's disease: a case report

  • By

  • Jianhua Huang

  • Dongya Wang

  • Yiwu Yu

  • Szeman Cheung

  • Li Xiao

  • Fei Miao

  • Wenjing Zha

  • Yitao Qian

  • Ke Li

  • Lei Shi

  • June 30, 2026

  • 0 min

Share

Objective:

To report a case of successful treatment of residual extramammary Paget's disease (EMPD) using intralesional aminolevulinic acid photodynamic therapy (ALA-PDT).

Approach:
  • Patient Background: An elderly male with scrotal EMPD underwent surgical excision, which revealed positive margins and tumor infiltration into subcutaneous fat.
  • Treatment Method: Intralesional 5-aminolevulinic acid (ALA) was injected monthly into the residual plaque, followed by light irradiation.
  • Monitoring and Results: The treatment involved three sessions, leading to marked thinning and fading of the plaque, with complete regression after six sessions.
Key Findings:
  • Intralesional ALA-PDT achieved complete clinical regression of residual EMPD.
  • The treatment was well-tolerated with mild pain and transient erythema.
  • No recurrence was observed during the 6-month follow-up period.
Interpretation:

Intralesional ALA-PDT is effective for treating EMPD with deep dermal invasion.

Limitations:
  • The study is based on a single case report, limiting generalizability.
  • Long-term efficacy and safety beyond 6 months remain to be established.
Conclusion:

Intralesional ALA-PDT represents a minimally invasive option for residual EMPD.

Original Source(s)

Related Content